Beam Therapeutics Inc 10-K for FY2024
Beam Therapeutics Inc. (BEAM)
10-K
2025-02-25
For: 2024-12-31
View Original
Added on
April 09, 2026
About this 10-K
Beam Therapeutics Inc filed this 10-K on February 25, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $63.52M
- down 83.2% from $377.71M a year earlier
- Net loss
- $376.74M
- compared with a net loss of $132.53M a year earlier
- Diluted EPS
- -$4.58
- compared with -$1.72 a year earlier